» Articles » PMID: 28691768

Microbiome, Inflammation, Epigenetic Alterations, and Mental Diseases

Overview
Date 2017 Jul 11
PMID 28691768
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Major mental diseases such as autism, bipolar disorder, schizophrenia, and major depressive disorder are debilitating illnesses with complex etiologies. Recent findings show that the onset and development of these illnesses cannot be well described by the one-gene; one-disease approach. Instead, their clinical presentation is thought to result from the regulative interplay of a large number of genes. Even though the involvement of many genes are likely, up regulating and activation or down regulation and silencing of these genes by the environmental factors play a crucial role in contributing to their pathogenesis. Much of this interplay may be moderated by epigenetic changes. Similar to genetic mutations, epigenetic modifications such as DNA methylation, histone modifications, and RNA interference can influence gene expression and therefore may cause behavioral and neuronal changes observed in mental disorders. Environmental factors such as diet, gut microbiota, and infections have significant role in these epigenetic modifications. Studies show that bioactive nutrients and gut microbiota can alter either DNA methylation and histone signatures through a variety of mechanisms. Indeed, microbes within the human gut may play a significant role in the regulation of various elements of "gut-brain axis," via their influence on inflammatory cytokines and production of antimicrobial peptides that affect the epigenome through their involvement in generating short chain fatty acids, vitamin synthesis, and nutrient absorption. In addition, they may participate in-gut production of many common neurotransmitters. In this review we will consider the potential interactions of diet, gastrointestinal microbiome, inflammation, and epigenetic alterations in psychiatric disorders.

Citing Articles

Exploring Multidisciplinary Approaches to Comorbid Psychiatric and Medical Disorders: A Scoping Review.

Tenea-Cojan S, Dinescu V, Gheorman V, Dragne I, Gheorman V, Fortofoiu M Life (Basel). 2025; 15(2).

PMID: 40003660 PMC: 11856229. DOI: 10.3390/life15020251.


Epigenetic Mechanisms in Aging: Extrinsic Factors and Gut Microbiome.

Borrego-Ruiz A, Borrego J Genes (Basel). 2025; 15(12.

PMID: 39766866 PMC: 11675900. DOI: 10.3390/genes15121599.


Association between small intestine bacterial overgrowth and psychiatric disorders.

Bogielski B, Michalczyk K, Glodek P, Tempka B, Gebski W, Stygar D Front Endocrinol (Lausanne). 2024; 15:1438066.

PMID: 39497810 PMC: 11532184. DOI: 10.3389/fendo.2024.1438066.


Efficacy and safety of BF839 for pediatric autism spectrum disorder: a randomized clinical trial.

Lin C, Zeng T, Lu C, Li D, Liu Y, Li B Front Nutr. 2024; 11:1447059.

PMID: 39290561 PMC: 11407114. DOI: 10.3389/fnut.2024.1447059.


An Anti-Inflammatory Diet and Its Potential Benefit for Individuals with Mental Disorders and Neurodegenerative Diseases-A Narrative Review.

van Zonneveld S, van den Oever E, Haarman B, Grandjean E, Nuninga J, van de Rest O Nutrients. 2024; 16(16).

PMID: 39203783 PMC: 11357610. DOI: 10.3390/nu16162646.


References
1.
Mirsepasi-Lauridsen H, Halkjaer S, Mortensen E, Lydolph M, Nordgaard-Lassen I, Krogfelt K . Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis. Sci Rep. 2016; 6:31152. PMC: 5043179. DOI: 10.1038/srep31152. View

2.
Paschos K, Allday M . Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends Microbiol. 2010; 18(10):439-47. PMC: 3089700. DOI: 10.1016/j.tim.2010.07.003. View

3.
Raison C, Miller A . The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol Psychiatry. 2012; 18(1):15-37. PMC: 3532038. DOI: 10.1038/mp.2012.2. View

4.
Andrews T, Zhang P, Bhat N . TNFalpha potentiates IFNgamma-induced cell death in oligodendrocyte progenitors. J Neurosci Res. 1998; 54(5):574-83. DOI: 10.1002/(SICI)1097-4547(19981201)54:5<574::AID-JNR2>3.0.CO;2-0. View

5.
Strawbridge R, Arnone D, Danese A, Papadopoulos A, Herane Vives A, Cleare A . Inflammation and clinical response to treatment in depression: A meta-analysis. Eur Neuropsychopharmacol. 2015; 25(10):1532-43. DOI: 10.1016/j.euroneuro.2015.06.007. View